RESUMO
Methylone is a synthetic derivative of cathinone. It is sold principally on the Internet in powder form under the name «bath salts¼. Deaths following consumption are very rare. This report details the first case of a death in France (a 21-year-old man), following ingestion of methylone during an evening with friends. Anoxia was observed at the time of autopsy. Toxicological analyses highlighted a consumption of methylone and cannabis. However, biological analyses showed an absence of ethanol, cocaine, amphetamines, and opiate derivatives. Likewise, no medications were found. High concentrations of methylone were found in the peripheral blood (3.13 mg/L) and in the central blood (6.64 mg/L). Its presence in the gastric contents provides evidence that the substance was taken orally. The dosage of δ9-tetrahydrocannabinol (THC) suggests a recent cannabis consumption (THC 12.9 µg/L, THC-COOH 29.3 µg/L, 11-OH-THC 4.9 µg/L). This case illustrates that the consumption of methylone, which has a reputation of being less «powerful¼ than ecstasy, is not without its dangers.
Assuntos
Estimulantes do Sistema Nervoso Central/análise , Estimulantes do Sistema Nervoso Central/intoxicação , Metanfetamina/análogos & derivados , Administração Oral , Bile/química , Estimulantes do Sistema Nervoso Central/administração & dosagem , Cromatografia Líquida de Alta Pressão , Dronabinol/análise , Toxicologia Forense , Cromatografia Gasosa-Espectrometria de Massas , Conteúdo Gastrointestinal/química , Humanos , Masculino , Metanfetamina/administração & dosagem , Metanfetamina/análise , Metanfetamina/intoxicação , Psicotrópicos/análise , Transtornos Relacionados ao Uso de Substâncias/complicações , Corpo Vítreo/química , Adulto JovemRESUMO
OBJECTIVES: Nevirapine is an inducer of hepatic metabolism. After discontinuation, nevirapine has an inductive effect on cytochrome P450 3A4, which persists for a few weeks and which, after switching to rilpivirine, may reduce rilpivirine exposures and have a negative clinical impact. This study evaluates the virological outcome, pharmacokinetics and safety of switching virologically suppressed, HIV-1-infected patients from nevirapine to rilpivirine. PATIENTS AND METHODS: This 24 week open-label single-centre study included HIV-1-infected adults with HIV-1 RNA <50 copies/mL for >6 months on tenofovir/emtricitabine and nevirapine, who were willing to simplify their regimen to tenofovir/emtricitabine/rilpivirine. Virological suppression, safety and nevirapine and rilpivirine pharmacokinetics were assessed. RESULTS: At weeks 12 and 24, all 32 subjects remained virologically suppressed. One subject discontinued at week 1 for rilpivirine-associated insomnia and two patients chose to resume tenofovir/emtricitabine and nevirapine after week 12 because of rilpivirine-associated food constraint. There was no grade 3/4 laboratory abnormality. Rilpivirine trough concentrations were above the mean trough concentrations observed in Phase 3 studies by 1 week post-switch. Twenty-seven out of 32 patients had no measurable levels of nevirapine by 2 weeks post-switch. The meal accompanying tenofovir/emtricitabine/rilpivirine intake satisfied food requirements in 81% of cases. Overall general satisfaction was improved in 90% of the subjects despite food constraints. CONCLUSION: Nevirapine has a short and limited inductive effect on rilpivirine metabolism, which is not clinically significant. Tenofovir/emtricitabine/rilpivirine is an efficacious and safe option for virologically suppressed HIV-infected patients on nevirapine wishing to simplify their regimen.
Assuntos
Terapia Antirretroviral de Alta Atividade , Infecções por HIV/tratamento farmacológico , Infecções por HIV/virologia , HIV-1 , Adenina/administração & dosagem , Adenina/análogos & derivados , Adulto , Contagem de Linfócito CD4 , Desoxicitidina/administração & dosagem , Desoxicitidina/análogos & derivados , Combinação de Medicamentos , Substituição de Medicamentos , Emtricitabina , Feminino , HIV-1/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade , Nevirapina/administração & dosagem , Nitrilas/administração & dosagem , Organofosfonatos/administração & dosagem , Estudos Prospectivos , Pirimidinas/administração & dosagem , Rilpivirina , Tenofovir , Resultado do Tratamento , Carga ViralAssuntos
Buprenorfina/efeitos adversos , Antagonistas de Entorpecentes/efeitos adversos , Síndrome de Nicolau/etiologia , Pele/patologia , Adulto , Buprenorfina/administração & dosagem , Feminino , França , Humanos , Injeções , Masculino , Pessoa de Meia-Idade , Antagonistas de Entorpecentes/administração & dosagem , Necrose/induzido quimicamente , Tratamento de Substituição de Opiáceos/efeitos adversos , Transtornos Relacionados ao Uso de Opioides/reabilitação , Estudos Prospectivos , Adulto JovemAssuntos
Coma/induzido quimicamente , Overdose de Drogas/etiologia , Ácido Valproico/análogos & derivados , Anticonvulsivantes/sangue , Anticonvulsivantes/farmacocinética , Anticonvulsivantes/intoxicação , Pré-Escolar , Overdose de Drogas/terapia , Feminino , Humanos , Intubação , Ácido Valproico/sangue , Ácido Valproico/farmacocinética , Ácido Valproico/intoxicaçãoRESUMO
Methicillin-resistant Staphylococcus aureus infection is a serious clinical problem worldwide. Ceftaroline, daptomycin, linezolid in combination with rifampicin are particularly used in this indication. To allow monitoring of these antibiotics, an on-line solid phase extraction coupled to high-performance liquid chromatography-tandem mass spectrometry assay requiring a 100 µL aliquot of human plasma has been developed. Besides, significance of 25-O-desacetylrifampicin concentrations was evaluated. Sample pre-treatment is limited to protein precipitation with methanol. After centrifugation 10 µL of supernatant are injected into the chromatographic system, which consists of an on-line solid phase extraction followed by a separation on a phenyl-hexyl column and detected by a tandem mass spectrometer. Plasma drug concentrations were determined by multiple reaction monitoring in positive ion mode, and assay performance was evaluated. 25-O-Desacetylrifampicin activity, was compared to rifampicin using a microbiological method. Sample preparation using methanol precipitation followed by solid-phase extraction yielded good recovery and ionization efficiency, with chromatographic separation achieved within 3 min per sample. Within-run and between-run precisions ranged respectively from 1.22% to 9.35% and from 1.61% to 9.36%. Lower limits of quantification were 0.04 mg/L for linezolid, 0.1mg/L for rifampicin, 0.2mg/L for ceftaroline and 0.5mg/L for daptomycin. It appears that 25-O-desacetylrifampicin displays a substantial intrinsic bactericidal activity against S. aureus. This assay provides simple, rapid, sensitive and accurate quantification of the four antibiotic drugs and one metabolite and can be routinely used to monitor drug concentration in methicillin-resistant S. aureus infected patients.
Assuntos
Cefalosporinas/sangue , Daptomicina/sangue , Linezolida/sangue , Rifampina/sangue , Extração em Fase Sólida/métodos , Espectrometria de Massas em Tandem/métodos , Antibacterianos/sangue , Cromatografia Líquida de Alta Pressão/métodos , Humanos , CeftarolinaRESUMO
A liquid chromatography-tandem mass spectrometry assay requiring a 100µL aliquot of human plasma for simultaneous determination of rilpivirine, a second generation non-nucleoside reverse transcriptase inhibitors of HIV and dolutegravir, a novel integrase stand transfer inhibitors of HIV concentrations has been developed. Sample pre-treatment is limited to protein precipitation with a mixture of methanol and zinc sulfate. After centrifugation the supernatant is injected in the chromatographic system, which consists of on-line solid phase extraction followed by separation on a phenyl-hexyl column. This 2.5min method, with its simple sample preparation provides sensitive (the limit of quantitation is 25ng/mL for each compound), accurate and precise (the intra-day and inter-day imprecision and inaccuracy are lower than 15%) quantification of the plasma concentration of these drugs and can be used for therapeutic drug monitoring in patients infected with HIV.
Assuntos
Fármacos Anti-HIV/sangue , Cromatografia Líquida/métodos , Compostos Heterocíclicos com 3 Anéis/sangue , Nitrilas/sangue , Pirimidinas/sangue , Espectrometria de Massas em Tandem/métodos , Precipitação Química , Cromatografia Líquida de Alta Pressão/métodos , Cromatografia Líquida/instrumentação , Monitoramento de Medicamentos/métodos , Infecções por HIV/sangue , Infecções por HIV/tratamento farmacológico , Inibidores de Integrase de HIV , Humanos , Oxazinas , Piperazinas , Piridonas , Inibidores da Transcriptase Reversa , Rilpivirina , Sensibilidade e Especificidade , Espectrometria de Massas em Tandem/instrumentaçãoRESUMO
The aims of this study were to evaluate pharmacokinetic (PK) parameters of total and unbound ertapenem (ERT) in burns patients and to identify which covariates influence these PK parameters. ERT plasma concentrations were measured in burns patients (n = 8) who received a 0.5-h infusion of ERT (1000 mg) every 24 h. PK parameters were estimated by a non-compartmental approach and the influence of covariates was estimated by multivariate analysis using a population approach. Clearance (CL) and the volume of distribution (V) of total ERT were lower than the results for unbound ERT [CL, 22.2 ± 5.6 mL/min vs. 279.4 ± 208.2 mL/min; V, 9.7 ± 1.4L vs. 120.6 ± 130.6L (mean ± standard deviation)]. Creatinine clearance (CL(Cr)) and the burned surface area (BSA) were the covariates identified that significantly (P<0.01) affected the pharmacokinetics of total ERT [CL (L/h)=0.373 +{0.00666 x CL(Cr) (mL/min)}] and unbound ERT [peripheral volume of distribution (L) = 3.05 + {0.959 x BSA (% of the total body surface)}], respectively. The influences of albuminaemia, glomerular filtration and burn wound on ERT pharmacokinetics are proposed to explain these results. These first results support that the ERT plasma concentration should be closely monitored particularly for patients with high values of BSA and/or CL(Cr) to avoid suboptimal exposure.
Assuntos
Antibacterianos/farmacocinética , Queimaduras , beta-Lactamas/farmacocinética , Adulto , Idoso , Antibacterianos/administração & dosagem , Ertapenem , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Estatísticos , Plasma/química , Estudos Prospectivos , Adulto Jovem , beta-Lactamas/administração & dosagemRESUMO
A simple chromatographic assay based on ultra high performance liquid chromatography with ultraviolet detection at 295 nm is proposed to determinate simultaneously human plasma concentrations of imipenem, doripenem, meropenem and ertapenem. After deproteinization by acetonitrile, carbapenems are separated on a PentaFluoroPhenyl column with a binary gradient elution. This method is specific, accurate, precise (the intra-day and inter-day imprecision and inaccuracy are lower than 15%), sensitive (the limit of quantitation is equal to 0.50 mg/L for imipenem, doripenem, ertapenem, meropenem) and not time consuming (run time=7 min). An application of this method to measure ertapenem plasma concentrations in burn patients is presented.